The cytosine deaminase APOBEC3B affects responses to therapy in estrogen receptor positive breast cancer cells

被引:0
|
作者
LaPara, Kelly S.
Law, Emily
Harris, Reuben
Yee, Douglas
机构
关键词
D O I
10.1158/1538-7445.AM2016-295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
295
引用
收藏
页数:3
相关论文
共 50 条
  • [41] DNA replication stress: a source of APOBEC3B expression in breast cancer
    David W. Cescon
    Benjamin Haibe-Kains
    Genome Biology, 17
  • [42] Progressive APOBEC3B mRNA expression in distant breast cancer metastases
    Sieuwerts, Anieta M.
    Schrijver, Willemijne A. M. E.
    Dalm, Simone U.
    de Weerd, Vanja
    Moelans, Cathy B.
    ter Hoeve, Natalie
    van Diest, Paul J.
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    PLOS ONE, 2017, 12 (01):
  • [43] The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
    Caswell, Deborah R.
    Gui, Philippe
    Mayekar, Manasi K.
    Law, Emily K.
    Pich, Oriol
    Bailey, Chris
    Boumelha, Jesse
    Kerr, D. Lucas
    Blakely, Collin M.
    Manabe, Tadashi
    Martinez-Ruiz, Carlos
    Bakker, Bjorn
    Villcas, Juan De Dios Palomino
    I. Vokes, Natalie
    Dietzen, Michelle
    Angelova, Mihaela
    Gini, Beatrice
    Tamaki, Whitney
    Allegakoen, Paul
    Wu, Wei
    Humpton, Timothy J.
    Hill, William
    Tomaschko, Mona
    Lu, Wei-Ting
    Haderk, Franziska
    Al Bakir, Maise
    Nagano, Ai
    Gimeno-Valiente, Francisco
    Trecesson, Sophie de Carne
    Vendramin, Roberto
    Barbe, Vittorio
    Mugabo, Miriam
    Weeden, Clare E.
    Rowan, Andrew
    McCoach, Caroline E.
    Almeida, Bruna
    Green, Mary
    Gomez, Carlos
    Nanjo, Shigeki
    Barbosa, Dora
    Moore, Chris
    Przewrocka, Joanna
    Black, James R. M.
    Gronroos, Eva
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    Zverev, Caroline
    Lighterness, Scott
    Cormack, James
    Olivas, Victor
    NATURE GENETICS, 2023, 56 (1) : 60 - 73
  • [44] APOBEC3B fuels evolution of resistance during targeted cancer therapy.
    Mayekar, Manasi K.
    Caswell, Deborah
    Vokes, Natalie
    Wu, Wei
    McCoach, Caroline
    Blakely, Collin
    Temiz, Nuri Alpay
    Kerr, Daniel Lucas
    Rotow, Julia
    Haderk, Franziska
    Cech, Lauren
    Gini, Beatrice
    Nanjo, Shigeki
    Tan, Lisa
    Yu, Johnny
    Gomez, Carlos
    Gui, Philippe
    Yu, Elizabeth
    Thomas, Nicholas
    Downward, Julian
    Harris, Reuben
    Van Allen, Eliezer
    Swanton, Charles
    Bivona, Trever
    CANCER RESEARCH, 2021, 81 (13)
  • [45] The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
    Deborah R. Caswell
    Philippe Gui
    Manasi K. Mayekar
    Emily K. Law
    Oriol Pich
    Chris Bailey
    Jesse Boumelha
    D. Lucas Kerr
    Collin M. Blakely
    Tadashi Manabe
    Carlos Martinez-Ruiz
    Bjorn Bakker
    Juan De Dios Palomino Villcas
    Natalie I. Vokes
    Michelle Dietzen
    Mihaela Angelova
    Beatrice Gini
    Whitney Tamaki
    Paul Allegakoen
    Wei Wu
    Timothy J. Humpton
    William Hill
    Mona Tomaschko
    Wei-Ting Lu
    Franziska Haderk
    Maise Al Bakir
    Ai Nagano
    Francisco Gimeno-Valiente
    Sophie de Carné Trécesson
    Roberto Vendramin
    Vittorio Barbè
    Miriam Mugabo
    Clare E. Weeden
    Andrew Rowan
    Caroline E. McCoach
    Bruna Almeida
    Mary Green
    Carlos Gomez
    Shigeki Nanjo
    Dora Barbosa
    Chris Moore
    Joanna Przewrocka
    James R. M. Black
    Eva Grönroos
    Alejandro Suarez-Bonnet
    Simon L. Priestnall
    Caroline Zverev
    Scott Lighterness
    James Cormack
    Victor Olivas
    Nature Genetics, 2024, 56 : 60 - 73
  • [46] p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
    Periyasamy, Manikandan
    Singh, Anup K.
    Gemma, Carolina
    Kranjec, Christian
    Farzan, Raed
    Leach, Damien A.
    Navaratnam, Naveenan
    Palinkas, Hajnalka L.
    Vertessy, Beata G.
    Fenton, Tim R.
    Doorbar, John
    Fuller-Pace, Frances
    Meek, David W.
    Coombes, R. Charles
    Buluwela, Laki
    Ali, Simak
    NUCLEIC ACIDS RESEARCH, 2017, 45 (19) : 11056 - 11069
  • [47] Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells
    Mishra, Nawneet
    Reddy, K. Sony
    Timilsina, Uddhav
    Gaur, Deepak
    Gaur, Ritu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (08) : 6695 - 6703
  • [48] APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
    Periyasamy, Manikandan
    Patel, Hetal
    Lai, Chun-Fui
    Nguyen, Van T. M.
    Nevedomskaya, Ekaterina
    Harrod, Alison
    Russell, Roslin
    Remenyi, Judit
    Ochocka, Anna Maria
    Thomas, Ross S.
    Fuller-Pace, Frances
    Gyorffy, Balazs
    Caldas, Carlos
    Navaratnam, Naveenan
    Carroll, Jason S.
    Zwart, Wilbert
    Coombes, R. Charles
    Magnani, Luca
    Buluwela, Laki
    Ali, Simak
    CELL REPORTS, 2015, 13 (01): : 108 - 121
  • [49] Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
    Serena Nik-Zainal
    David C Wedge
    Ludmil B Alexandrov
    Mia Petljak
    Adam P Butler
    Niccolo Bolli
    Helen R Davies
    Stian Knappskog
    Sancha Martin
    Elli Papaemmanuil
    Manasa Ramakrishna
    Adam Shlien
    Ingrid Simonic
    Yali Xue
    Chris Tyler-Smith
    Peter J Campbell
    Michael R Stratton
    Nature Genetics, 2014, 46 : 487 - 491
  • [50] The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
    Liu, Jingjing
    Sieuwerts, Anieta M.
    Look, Maxime P.
    van der Vlugt-Daane, Michelle
    Meijer-van Gelder, Marion E.
    Foekens, John A.
    Hollestelle, Antoinette
    Martens, John W. M.
    PLOS ONE, 2016, 11 (08):